Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Chapman

Showing results (311-320 of 345) with videos related to

Pageof 35
Sort By:
Journal of Medicinal Chemistry|October 17, 2017
Hit-to-Lead Optimization and Discovery of 5-((5-([1,1'-Biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic Acid (MK-3903): A Novel Class of Benzimidazole-Based Activators of AMP-Activated Protein KinasePing Lan, F Anthony Romero, Dariusz Wodka, et al.
Bioorganic & Medicinal Chemistry Letters|September 14, 2010
Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activitiesHaifeng Tang, Yan Yan, Zhe Feng, et al.
Faraday Discussions|November 22, 2014
Formation of coherent rotational wavepackets in small molecule-helium clusters using impulsive alignmentGediminas Galinis, Luis G Mendoza Luna, Mark J Watkins, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptorJoseph L Duffy, Brian A Kirk, Zenon Konteatis, et al.
American Journal of Respiratory and Critical Care Medicine|October 8, 2005
The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollmentJay H Ryu, Joel Moss, Gerald J Beck, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole coreDong-Ming Shen, Edward J Brady, Mari R Candelore, et al.
The Lancet. Respiratory Medicine|October 26, 2013
Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trialLisa Young, Hye-Seung Lee, Yoshikazu Inoue, et al.
The European Respiratory Journal|March 9, 2019
Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosisNishant Gupta, Hye-Seung Lee, Lisa R Young, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
1,3,4 Trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chainsChristopher A Willoughby, Keith G Rosauer, Jeffery J Hale, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIVChristopher L Lynch, Jeffrey J Hale, Richard J Budhu, et al.
Pageof 35

Showing results (311-320 of 345) with videos related to

Sort By:
Pageof 35
Journal of Medicinal Chemistry|October 17, 2017
Hit-to-Lead Optimization and Discovery of 5-((5-([1,1'-Biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic Acid (MK-3903): A Novel Class of Benzimidazole-Based Activators of AMP-Activated Protein KinasePing Lan, F Anthony Romero, Dariusz Wodka, et al.
Bioorganic & Medicinal Chemistry Letters|September 14, 2010
Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activitiesHaifeng Tang, Yan Yan, Zhe Feng, et al.
Faraday Discussions|November 22, 2014
Formation of coherent rotational wavepackets in small molecule-helium clusters using impulsive alignmentGediminas Galinis, Luis G Mendoza Luna, Mark J Watkins, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptorJoseph L Duffy, Brian A Kirk, Zenon Konteatis, et al.
American Journal of Respiratory and Critical Care Medicine|October 8, 2005
The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollmentJay H Ryu, Joel Moss, Gerald J Beck, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole coreDong-Ming Shen, Edward J Brady, Mari R Candelore, et al.
The Lancet. Respiratory Medicine|October 26, 2013
Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trialLisa Young, Hye-Seung Lee, Yoshikazu Inoue, et al.
The European Respiratory Journal|March 9, 2019
Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosisNishant Gupta, Hye-Seung Lee, Lisa R Young, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
1,3,4 Trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chainsChristopher A Willoughby, Keith G Rosauer, Jeffery J Hale, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIVChristopher L Lynch, Jeffrey J Hale, Richard J Budhu, et al.
Pageof 35